Pilatus Biosciences Announces First Patient Dosed in Phase 1 Trial of First-in-Class Metabolic Checkpoint Antibody PLT012 in Solid Tumors ...
Walk through any grocery store and the packages scream at you. Natural. Lightly sweetened. Made with real fruit. The labels promise health, purity, and goodness wrapped in convenient packaging. We ...
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced new open-label extension study data for repinatrabit (JNT-517), demonstrating ...